Shares of ARYA Sciences Acquisition Corp V (NASDAQ:ARYE – Get Rating) traded up 0.4% during trading on Friday . The company traded as high as $10.09 and last traded at $10.09. 150 shares traded hands during trading, a decline of 100% from the average session volume of 70,190 shares. The stock had previously closed at $10.05.
ARYA Sciences Acquisition Corp V Stock Performance
The stock's 50 day moving average is $9.98 and its 200 day moving average is $9.85.
Get
ARYA Sciences Acquisition Corp V alerts:
Institutional Trading of ARYA Sciences Acquisition Corp V
A number of institutional investors have recently modified their holdings of ARYE. Sculptor Capital LP increased its holdings in ARYA Sciences Acquisition Corp V by 147.8% during the 1st quarter. Sculptor Capital LP now owns 805,297 shares of the company's stock worth $7,819,000 after acquiring an additional 480,297 shares during the period. Aristeia Capital LLC bought a new position in shares of ARYA Sciences Acquisition Corp V in the 3rd quarter worth $7,711,000. Cantor Fitzgerald L. P. increased its holdings in shares of ARYA Sciences Acquisition Corp V by 532.7% in the 3rd quarter. Cantor Fitzgerald L. P. now owns 632,668 shares of the company's stock worth $6,206,000 after buying an additional 532,668 shares during the last quarter. Westchester Capital Management LLC increased its holdings in shares of ARYA Sciences Acquisition Corp V by 248.6% in the 3rd quarter. Westchester Capital Management LLC now owns 270,608 shares of the company's stock worth $2,652,000 after buying an additional 192,972 shares during the last quarter. Finally, Radcliffe Capital Management L.P. increased its holdings in shares of ARYA Sciences Acquisition Corp V by 0.7% in the 1st quarter. Radcliffe Capital Management L.P. now owns 201,374 shares of the company's stock worth $1,959,000 after buying an additional 1,374 shares during the last quarter. 70.45% of the stock is currently owned by hedge funds and other institutional investors.
ARYA Sciences Acquisition Corp V Company Profile
(Get Rating)
ARYA Sciences Acquisition Corp V does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses in the healthcare and healthcare-related industries. The company was incorporated in 2021 and is based in New York, New York.
See Also
- Get a free copy of the StockNews.com research report on ARYA Sciences Acquisition Corp V (ARYE)
- MarketBeat: Week in Review 12/26 – 12/30
- The Dogs Of Tech: It's Time For A Bite Of These Stocks
- Does This Acquisition Make Microsoft a Bear Market Buy?
- Is Kintara Therapeutics A Hidden Gem?
- Should You Warm up to Generac Stock for the Winter?
Receive News & Ratings for ARYA Sciences Acquisition Corp V Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARYA Sciences Acquisition Corp V and related companies with MarketBeat.com's FREE daily email newsletter.
ナスダック：ARYE-GET格付け会社の株は金曜日の取引で0.4%上昇した。同社の株価は一時10.09ドルに達し、最新は10.09ドルだった。当日は150株が成約し、70，190株の平均日成約量より100%低下した。同株のこれまでの終値は10.05ドル。
Arya Sciences Acquisition Corp V株表現
この株の50日移動平均線切り込み位は9.98ドル，200日移動平均線切り込み位は9.85ドルであった
それを手に入れて
Arya SciencesがVを買収した警報：
Arya SciencesがVを買収した機関取引
一部の機関投資家たちは最近Aryeに対する株式保有を修正した。彫刻家資本有限公司は第1四半期にArya Sciences Acquisition Corp V 147.8%の株式を増資した。この間、彫刻家Capital LPは480，297株を追加買収し、現在805，297株の会社株を保有しており、7，819，000ドルの価値がある。Aristeia Capital LLCは第3四半期にArya Sciences Acquisition Corp Vの新頭寸を購入し，7，711，000ドルの価値があった。Cantor Fitzgerald L.P.は第3四半期にArya Sciences Acquisition Corp Vの株532.7%を増収した。コントー·フィッツジェラルドは現在、同社632，668株を保有しており、6，206，000ドルの価値があり、前四半期に532，668株を購入している。Westchester Capital Management LLCは第3四半期にArya Sciences Acquisition Corp Vの株248.6%を増資した。Westchester Capital Management LLCは現在270，608株の同社株を保有しており、2，652，000ドルの価値があり、前四半期に192，972株を購入した。最後に，Radcliffe Capital Management L.P.は第1四半期にArya Sciences Acquisition Corp Vの株を0.7%増加させた.Radcliffe Capital Management L.P.は前四半期に1，374株を追加購入した後，現在201，374株を保有しており，1，959，000ドルの価値がある。70.45%の株式は現在ヘッジファンドと他の機関投資家が保有している
Arya Sciences Acquisition Corp V社の概要
(格付けを取得する)
Arya Sciences Acquisition Corp Vには重大な業務がない。それは、医療および医療関連業界の1つまたは複数の業務と合併、株式交換、資産買収、株式購入、再編または関連業務の合併を行うことを意図している。同社は2021年に設立され、ニューヨークに本社を置いている。
別項参照
- Arya Sciences Acquisition Corp V(Arye)に関するStockNews.comの研究報告を無料で取得
- MarketBeat：1週間を振り返る12/26-12/30
- 科学技術犬：この株を噛む時だ
- この買収はマイクロソフトを熊市購入者にするのでしょうか？
- キンタラ治療会社は隠れた宝石ですか？
- ゼネック株の冬を過ごすまで体を温めるべきですか
Arya Sciences Acquisition Corp V Dailyのニュースと格付けを獲得-MarketBeat.comの無料毎日電子メール時事通信を介して、Arya Sciences Acquisition Corp Vおよび関連会社の最新のニュースおよびアナリスト格付けの簡明な毎日要約を以下に入力します。
